Episode 2: Remdesivir, antivirals and COVID-19

from NPS MedicineWise Podcasts · host NPS Medicinewise

Currently there are no approved medicines to treat COVID-19. However, there are several trials underway assessing the role of antiviral medicines, including remdesivir, in the treatment of COVID-19. In this episode, NPS MedicineWise medical adviser and GP Dr Anna Samecki talks with CEO Adj A/Prof Steve Morris about the latest evidence for remdesivir and what this might mean for treating COVID-19.

Episode metadata supplied by the publisher feed · Published May 22, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 2: Remdesivir, antivirals and COVID-19

0:00 5:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NPS MedicineWise Podcasts?

This episode is 5 minutes long.

When was this NPS MedicineWise Podcasts episode published?

This episode was published on May 22, 2020.

Can I download this NPS MedicineWise Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!